Needham has initiated coverage on Astrana Health Inc (ASTH) with a Buy rating, reflecting the firm's assessment of the company's investment potential. The action, taken on December 11, 2025, marks the beginning of Needham's evaluation of Astrana's position within the healthcare sector.
Astrana Health, headquartered in Alhambra, California, is a physician-centric, technology-powered healthcare management company. It employs 1,900 full-time staff and offers care coordination services across the healthcare delivery system. The firm operates through three segments: Care Partners, Care Delivery, and Care Enablement, supporting over 20,000 providers.
As of November 20, 2025, Astrana Health has a market capitalization of $1.1 billion, a P/E ratio of 110.18, and earnings per share (EPS) of $0.19. Upcoming earnings reports are anticipated on May 6, 2026, with an estimated EPS of $0.25 and revenue of $951.5 million, followed by a report on August 5, 2026, with an estimated EPS of $0.33 and revenue of $986.5 million.
The analyst consensus for Astrana Health stands at 7 Strong Buy, 6 Buy, and 3 Hold ratings, indicating a general favorable outlook among analysts.
Analyst ratings and price targets provide insights based on research and financial models. However, they are based on assumptions that may not materialize as anticipated. Investors should consider a range of factors, including company fundamentals, competitive positioning, and industry trends, when making decisions.